Vivek Garipalli
CIK 1839260 · View on SEC EDGAR ↗
First SEC filing: April 28, 2023 · Latest: April 28, 2023
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2023 | CLOV | M | 1,569,594 | — | — | 3,450,977 Direct | -31.26% | Disposed | (price as of 2026-08-20) |
| Jan. 7, 2023 | CLOV | M | 3,342,698 | — | — | 5,020,571 Direct | +199.22% | Acquired | (price as of 2026-08-20) |
| Jan. 7, 2023 | CLOV | M | 3,342,698 | — | — | 10,028,095 Direct | -25.00% | Disposed | (price as of 2026-08-20) |
| Jan. 7, 2023 | CLOV | F | 1,569,594 | $1.01 | $1,585,290 | 0 Direct | -100.00% | Disposed | 318.8% (price as of 2026-08-20) |
| Jan. 7, 2023 | CLOV | M | 1,569,594 | — | — | 1,569,594 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 7, 2021 | CLOV | A | 5,571,164 | — | — | 5,571,164 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 7, 2021 | CLOV | A | 16,713,491 | — | — | 16,713,491 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 7, 2021 | CLOV | A | 7,164,581 | — | — | 7,164,581 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 7, 2021 | CLOV | A | 2,062,265 | — | — | 2,062,265 Indirect | — | Acquired | (price as of 2026-08-20) |
| Jan. 7, 2021 | CLOV | A | 5,645,934 | — | — | 5,645,934 Indirect | — | Acquired | (price as of 2026-08-20) |
| Jan. 7, 2021 | CLOV | A | 182,201 | — | — | 182,201 Indirect | — | Acquired | (price as of 2026-08-20) |
| Jan. 7, 2021 | CLOV | A | 75,694,143 | — | — | 75,694,143 Indirect | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 7, 2023 | CLOV | Class B Common Stock | Class A Common Stock (1,569,594) | — | — | 1,569,594 | Disposed |
| Jan. 7, 2023 | CLOV | Class B Common Stock | Class A Common Stock (3,342,698) | — | — | 3,342,698 | Acquired |
| Jan. 7, 2023 | CLOV | Restricted Stock Unit | Class B Common Stock [F3] (3,342,698) | — | — | 3,342,698 | Disposed |
| Jan. 7, 2021 | CLOV | Performance-based Restricted Stock Units | Class B Common Stock [F1] (5,571,164) | — | — | 5,571,164 | Acquired |
| Jan. 7, 2021 | CLOV | Restricted Stock Units | Class B Common Stock [F1] (16,713,491) | — | — | 16,713,491 | Acquired |
| Jan. 7, 2021 | CLOV | Performance-based Restricted Stock Units | Class B Common Stock [F1] (7,164,581) | — | — | 7,164,581 | Acquired |
| Jan. 7, 2021 | CLOV | Class B Common Stock | Class A Common Stock (2,062,265) | — | — | 2,062,265 | Acquired |
| Jan. 7, 2021 | CLOV | Class B Common Stock | Class A Common Stock (5,645,934) | — | — | 5,645,934 | Acquired |
| Jan. 7, 2021 | CLOV | Class B Common Stock | Class A Common Stock (182,201) | — | — | 182,201 | Acquired |
| Jan. 7, 2021 | CLOV | Class B Common Stock | Class A Common Stock (75,694,143) | — | — | 75,694,143 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | — | — | — | — | — | — | — | — |
| 2021 | — | — | $389,569,439 | — | — | — | — | $389,569,439 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.